Peer reviewed

Tirzepatide once weekly for the treatment of obesity

Randomized SURMOUNT-1 obesity trial of tirzepatide.

New England Journal of MedicinePublished 2022-06-04Accessed 2026-07-12

Open original source

Registry record

Source metadata

Publisher
New England Journal of Medicine
Source type
Peer reviewed
Registry ID
nejm-tirzepatide-surmount1-video

Interpretation boundary

What this record can and cannot establish

Inclusion in the registry is not endorsement. The record supports only the claims that fit its design, population, date, and scope. Company, media, and community records can document that a claim was made without proving the claim itself.